(Q59326880)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30477458%20AND%20SRC:MED&resulttype=core&format=json

5 May 2020

1 reference

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30477458%20AND%20SRC:MED&resulttype=core&format=json

5 May 2020

Ze-Hao Huang

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30477458%20AND%20SRC:MED&resulttype=core&format=json

5 May 2020

Xiao-Wen Ma

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30477458%20AND%20SRC:MED&resulttype=core&format=json

5 May 2020

Jing Zhang

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30477458%20AND%20SRC:MED&resulttype=core&format=json

5 May 2020

Xiao Li

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30477458%20AND%20SRC:MED&resulttype=core&format=json

5 May 2020

Na-Lin Lai

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30477458%20AND%20SRC:MED&resulttype=core&format=json

5 May 2020

language of work or name

English

0 references

publication date

26 November 2018

0 references

published in

BMC Cancer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30477458%20AND%20SRC:MED&resulttype=core&format=json

5 May 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30477458%20AND%20SRC:MED&resulttype=core&format=json

5 May 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30477458%20AND%20SRC:MED&resulttype=core&format=json

5 May 2020

page(s)

1170

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30477458%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution 4.0 International

5 May 2020

start time

26 November 2018

1 reference

April 2022 Public Data File from Crossref

copyrighted

0 references

cites work

Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus

1 reference

12 December 2020

Prognostic significance of epidermal growth factor receptor in esophageal squamous cell carcinomas

1 reference

12 December 2020

Epidermal growth factor receptor overexpression in esophageal carcinoma. An immunohistochemical study correlated with clinicopathologic findings and DNA amplification

1 reference

12 December 2020

Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group

1 reference

12 December 2020

Measuring inconsistency in meta-analyses

1 reference

12 December 2020

Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer

1 reference

12 December 2020

Diffuse EGFR staining is associated with reduced overall survival in locally advanced oesophageal squamous cell cancer

1 reference

12 December 2020

EGFR protein overexpression and gene amplification in squamous cell carcinomas of the esophagus

1 reference

12 December 2020

Prognostic significance of expression patterns of c-erbB-2, p53, p16INK4A, p27KIP1, cyclin D1 and epidermal growth factor receptor in oesophageal adenocarcinoma: a tissue microarray study

1 reference

12 December 2020

Expression of epidermal growth factor receptor in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome

1 reference

12 December 2020

Platinum-based chemotherapy plus cetuximab in head and neck cancer

1 reference

12 December 2020

Cetuximab plus cisplatin-5-fluorouracil versus cisplatin-5-fluorouracil alone in first-line metastatic squamous cell carcinoma of the esophagus: a randomized phase II study of the Arbeitsgemeinschaft Internistische Onkologie.

1 reference

12 December 2020

Modulation of cellular redox state underlies antagonism between oxaliplatin and cetuximab in human colorectal cancer cell lines

1 reference

12 December 2020

Cetuximab and chemoradiation for rectal cancer--is the water getting muddy?

1 reference

12 December 2020

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

1 reference

12 December 2020

Targeting the human EGFR family in esophagogastric cancer

1 reference

12 December 2020

Technical considerations in radiation therapy for gastroesophageal junction cancer

1 reference

12 December 2020

Capecitabine and cisplatin with or without cetuximab for patients with previously untreated advanced gastric cancer (EXPAND): a randomised, open-label phase 3 trial

1 reference

12 December 2020

Epirubicin, oxaliplatin, and capecitabine with or without panitumumab for patients with previously untreated advanced oesophagogastric cancer (REAL3): a randomised, open-label phase 3 trial

1 reference

12 December 2020

Chemoradiotherapy with or without cetuximab in patients with oesophageal cancer (SCOPE1): a multicentre, phase 2/3 randomised trial

1 reference

12 December 2020

Reduced lung dose during radiotherapy for thoracic esophageal carcinoma: VMAT combined with active breathing control for moderate DIBH.

1 reference

12 December 2020

Cancer statistics, 2014

1 reference

12 December 2020

Yoga for prenatal depression: a systematic review and meta-analysis.

1 reference

12 December 2020

Cetuximab in patients with esophageal cancer: a systematic review and meta-analysis of randomized controlled trials.

1 reference

12 December 2020

The relationship between the expression of VEGF, EGFR, and HER-2 mRNA in esophageal squamous cell carcinoma (ESCC) and clinicopathological features of different ethnic groups in Xinjiang

1 reference

12 December 2020

Long-term results and recurrence patterns from SCOPE-1: a phase II/III randomised trial of definitive chemoradiotherapy +/- cetuximab in oesophageal cancer.

1 reference

12 December 2020

Effect of the Addition of Cetuximab to Paclitaxel, Cisplatin, and Radiation Therapy for Patients With Esophageal Cancer: The NRG Oncology RTOG 0436 Phase 3 Randomized Clinical Trial

1 reference

12 December 2020

Cardiovascular Risk Following Fertility Therapy: Systematic Review and Meta-Analysis

1 reference

12 December 2020

Neo-adjuvant chemotherapy followed by chemoradiation and surgery with and without cetuximab in patients with resectable esophageal cancer: a randomized, open-label, phase III trial (SAKK 75/08).

1 reference

12 December 2020

10.1186/S12885-018-5040-Z

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30477458%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

5 May 2020

1110209745

0 references

Fatcat ID

release_obvqpy2xnngk7hvrw2dskqbpy4

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30477458%20AND%20SRC:MED&resulttype=core&format=json

5 May 2020

PubMed publication ID

30477458

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30477458%20AND%20SRC:MED&resulttype=core&format=json